Rallybio (RLYB) Prepaid Assets (2020 - 2026)
Rallybio (RLYB) posted Prepaid Assets of $6.7 million for Q1 2026, up 2.73% sequentially from $6.5 million in Q4 2025, and up 667.78% YoY from $872000.0 in Q1 2025.
Rallybio (RLYB) Prepaid Assets (2020 - 2026) Analysis & Trends
Rallybio has reported Prepaid Assets for 7 years, with the latest figure at $6.7 million in Q1 2026.
- Quarterly Prepaid Assets rose 667.78% year-over-year to $6.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (up 667.78% YoY) and the FY2025 annual result came in at $6.5 million, up 179.7% from the prior year.
- Prepaid Assets rose to $6.7 million in Q1 2026 per RLYB's latest filing, from $6.5 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $11.0 million in Q3 2023 and troughed at $872000.0 in Q1 2025.
- A 5-year average of $5.4 million and a median of $4.5 million in 2025 frame the typical range for Prepaid Assets.
- The widest YoY moves for Prepaid Assets: up 838.61% in 2023, down 80.44% in 2023.
- Over 5 years, Prepaid Assets stood at $10.5 million in 2022, then sank by 80.44% to $2.1 million in 2023, then climbed by 13.44% to $2.3 million in 2024, then jumped by 179.7% to $6.5 million in 2025, then rose by 2.73% to $6.7 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $6.7 million, $6.5 million, and $2.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Rallybio | 94.61 Mn | 94.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.40 Mn |
| Mar 31, 2026 | 6.70 Mn |
| Dec 31, 2025 | 6.52 Mn |
| Sep 30, 2025 | 2.67 Mn |
| Jun 30, 2025 | 4.52 Mn |
| Mar 31, 2025 | 872,000.00 |
| Dec 31, 2024 | 2.33 Mn |
| Sep 30, 2024 | 3.09 Mn |
| Jun 30, 2024 | 2.82 Mn |
| Mar 31, 2024 | 4.37 Mn |
| Dec 31, 2023 | 2.05 Mn |
| Sep 30, 2023 | 11.04 Mn |
| Jun 30, 2023 | 9.00 Mn |
| Mar 31, 2023 | 10.89 Mn |
| Dec 31, 2022 | 10.50 Mn |
| Sep 30, 2022 | 1.18 Mn |
| Jun 30, 2022 | 6.93 Mn |
| Mar 31, 2022 | 6.37 Mn |
| Dec 31, 2021 | 5.54 Mn |
| Sep 30, 2021 | 5.41 Mn |